Delos Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Buy
+136
New +$139K 0.08% 90
2026
Q1
Sell
-1
Closed -$1.07K 290
2025
Q4
$1.07K Hold
1
﹤0.01% 242
2025
Q3
$763 Sell
1
-12
-92% -$8.93K ﹤0.01% 271
2025
Q2
$10.1K Buy
+13
New +$10.1K 0.01% 170
2025
Q1
Sell
-12
Closed -$9.26K 127
2024
Q4
$9.26K Buy
+12
New +$9.94K 0.01% 114
2024
Q3
Sell
-13
Closed -$11.8K 288
2024
Q2
$11.8K Hold
13
0.01% 121
2024
Q1
$10.1K Buy
13
+11
+550% +$7.83K 0.01% 125
2023
Q4
$1.17K Sell
2
-89
-98% -$51.9K ﹤0.01% 177
2023
Q3
$50.4K Hold
91
0.06% 68
2023
Q2
$42.7K Hold
91
0.05% 71
2023
Q1
$31.3K Hold
91
0.04% 74
2022
Q4
$33.3K Hold
91
0.05% 71
2022
Q3
$29K Buy
91
+2
+2% +$634 0.03% 69
2022
Q2
$29K Hold
89
0.03% 74
2022
Q1
$25K Sell
89
-73
-45% -$18.8K 0.02% 99
2021
Q4
$45K Buy
+162
New +$41.1K 0.04% 82

Other funds holding LLY

Delos Wealth Advisors's LLY Position: Q2 2026 in Review

Delos Wealth Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 136 shares worth $163K. The stake represents 0.08% of the portfolio and ranks #90 among its holdings. This is a return to the name: Delos Wealth Advisors previously reported a position in LLY as recently as Q4 2025.

Delos Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Delos Wealth Advisors held 136 shares of Eli Lilly worth $163K as of Q2 2026.
  • Eli Lilly was a new Delos Wealth Advisors position in Q2 2026.
  • Eli Lilly made up 0.08% of Delos Wealth Advisors's portfolio in Q2 2026, its #90 holding.
  • Delos Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.